Walder Wyss has advised TECregen. TECregen, a biotechnology company based in Basel, Switzerland, has raised CHF 10 million through a seed financing round. The company undertook…
TECregen Secures CHF 10 Million in Seed Round for Thymus Regeneration
Walder Wyss has advised TECregen. TECregen, a biotechnology company based in Basel, Switzerland, has raised CHF 10 million through a seed financing round. The company undertook…